Phase 2/3 Study for the Evaluation of Safety and Efficacy of HAV for Vascular Reconstruction in Patients With Limb- or Life-threatening Vascular Trauma

Journal article

Peer reviewed

Ernest E. Moore, Charles J. Fox, Michael A. Curi, Rishi Kundi, Ying W. Lum, Nicholas Namias, Ravi R. Rajani, Laura E. Niklason and Shamik J. Parikh

Journal of vascular surgery, Vol.79(4), pp.45S-46S

2024-04

Metrics

1 Record Views

Title: Phase 2/3 Study for the Evaluation of Safety and Efficacy of HAV for Vascular Reconstruction in Patients With Limb- or Life-threatening Vascular Trauma
Creators: Ernest E. Moore - Denver Health Medical Center
Charles J. Fox - University of Maryland
Michael A. Curi - Rutgers New Jersey Medical School
Rishi Kundi - R Adams Cowley Shock Trauma Center
Ying W. Lum - Johns Hopkins Hospital
Nicholas Namias - Ryder Trauma Center
Ravi R. Rajani - Grady Memorial Hospital
Laura E. Niklason - Humacyte
Shamik J. Parikh - Humacyte
Publication Details: Journal of vascular surgery, Vol.79(4), pp.45S-46S
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Trauma & Surgical Critical Care Services
Language: English
Resource Type: Journal article
Record Identifier: 991032013218902976